European Medicines Agency (EMA) | What's new 中文 关注 孤儿药指定：ivosidenib 治疗骨髓增生异常综合征，2025/07/18 积极 Orphan designation: Ivosidenib Treatment of myelodysplastic syndromes, 18/07/2025 Positive ema.europa.eu
